ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
Study sponsor: Polaris Group
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-02-28Estimated
Enrollment · participants100Actual
Source updated2025-08-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.